Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Lopantrol, Socainide hydrochloride, Isocainide hydrochloride, Lorcainide hydrochloride [usan], Einecs 261-504-6, N-(4-chlorophenyl)-2-phenyl-n-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride
Molecular Formula
C22H28Cl2N2O
Molecular Weight
407.4  g/mol
InChI Key
FSFSWNBDCJVFGI-UHFFFAOYSA-N

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride
2.1.2 InChI
InChI=1S/C22H27ClN2O.ClH/c1-17(2)24-14-12-21(13-15-24)25(20-10-8-19(23)9-11-20)22(26)16-18-6-4-3-5-7-18;/h3-11,17,21H,12-16H2,1-2H3;1H
2.1.3 InChI Key
FSFSWNBDCJVFGI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)[NH+]1CCC(CC1)N(C2=CC=C(C=C2)Cl)C(=O)CC3=CC=CC=C3.[Cl-]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 4'-chloro-n-(1-isopropyl-4-piperidyl)-2-phenylacetanilide

2. Lorcainid

3. Lorcainide

4. Lorcainide Monohydrochloride

5. R 15889

6. R15889

7. Ro 13-1042

2.2.2 Depositor-Supplied Synonyms

1. Lopantrol

2. Socainide Hydrochloride

3. Isocainide Hydrochloride

4. Lorcainide Hydrochloride [usan]

5. Einecs 261-504-6

6. N-(4-chlorophenyl)-2-phenyl-n-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride

7. Ro 13-1042

8. Lorivox

9. R 15889

10. 1t1s98onm1

11. 1313498-17-7

12. Benzeneacetamide, N-(4-chlorophenyl)-n-(1-(1-methylethyl)-4-piperidinyl)-, Monohydrochloride

13. Lorcainida Clorhidrato [spanish]

14. Lorcainida Clorhidrato

15. Unii-1t1s98onm1

16. N-(p-chlorophenyl)-n-(1-isopropylpiperidin-4-yl)phenylacetamide Hydrochloride

17. Nsc 310411

2.3 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 407.4 g/mol
Molecular Formula C22H28Cl2N2O
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count5
Exact Mass406.1578689 g/mol
Monoisotopic Mass406.1578689 g/mol
Topological Polar Surface Area24.8 Ų
Heavy Atom Count27
Formal Charge0
Complexity433
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)